S. Cinieri Et Al. , "Final results of an international three-arm randomised phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer (NorCap-CA223 trial)," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , vol.49, Amsterdam, Netherlands, 2013
Cinieri, S. Et Al. 2013. Final results of an international three-arm randomised phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer (NorCap-CA223 trial). European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , (Amsterdam, Netherlands).
Cinieri, S., Chan, A., Altundag, K., Tubiana-Mathieu, N., Barnadas, A., Dodyk, P., ... Lazzarelli, S.(2013). Final results of an international three-arm randomised phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer (NorCap-CA223 trial) . European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands
Cinieri, S. Et Al. "Final results of an international three-arm randomised phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer (NorCap-CA223 trial)," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 2013
Cinieri, S. Et Al. "Final results of an international three-arm randomised phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer (NorCap-CA223 trial)." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013
Cinieri, S. Et Al. (2013) . "Final results of an international three-arm randomised phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer (NorCap-CA223 trial)." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands.
@conferencepaper{conferencepaper, author={S. Cinieri Et Al. }, title={Final results of an international three-arm randomised phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer (NorCap-CA223 trial)}, congress name={European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO}, city={Amsterdam}, country={Netherlands}, year={2013}}